JPRN-UMIN000002257已完成1 期
Phase I/II study of intravenous and intraperitoneal paclitaxel combined with continuous intraperitoneal cisplatin for advanced gastric cancer with peritoneal metastasis - Phase I/II study of intravenous and intraperitoneal paclitaxel combined with continuous intraperitoneal cisplatin for advanced gastric cancer with peritoneal metastasis
Department of Surgical Oncology, The University of Tokyo0 个研究点目标入组 25 人开始时间: 2009年8月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Metastasis to distant organ sites (such as the liver, lungs or bone), other active concomitant malignancies, or other severe medical conditions.
研究者
相似试验
已完成
不适用
Phase I/II study of intravenous and intraperitoneal paclitaxel for peritoneal metastasis after resection of pancreatic cancer refractory to gemcitabine and fluoropyrimidine chemotherapyPeritoneal metastasis after resection of pancreatic cancer refractory to gemcitabine and fluoropyrimidine chemotherapyJPRN-UMIN000016670Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine35
已完成
2 期
Phase II study of intravenous and intraperitoneal paclitaxel combined with S-1 for gastric cancer with peritoneal metastasisgastric cancer with peritoneal metastasisJPRN-UMIN000002850Department of Surgical Oncology, The University of Tokyo56
招募中
1 期
A phase 1 clinical trial of intraperitoneal administration of iCAR-ILC/N101 for ovarian clear cell carcinomaPatients with GPC3-expressing advanced ovarian clear cell carcinoma with peritoneal disseminationovarian clear cell carcinomaJPRN-jRCT2033200431Harano Kenichi18
已完成
不适用
Phase I/IIa study of intravesical administration of 2-methyl-3-butenyl-1-pyrophosphate-stimulated gamma delta T cells in patients with non-invasive bladder cancer.on-invasive bladder cancerJPRN-UMIN000010942Tokyo Women's Medical University12
已完成
1 期
Phase I study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 and intraperitoneal infusion of nafamostat mesilate for gastric cancer with peritoneal disseminatioGastric cancer with peritoneal disseminationJPRN-UMIN000018658The Jikei University School of Medicine18